| Literature DB >> 33450210 |
Ann-Katrin Hopp1, Federico Teloni1, Lavinia Bisceglie1, Corentin Gondrand2, Fabio Raith3, Kathrin Nowak1, Lukas Muskalla4, Anna Howald5, Patrick G A Pedrioli6, Kai Johnsson2, Matthias Altmeyer5, Deena M Leslie Pedrioli5, Michael O Hottiger7.
Abstract
In addition to its role as an electron transporter, mitochondrial nicotinamide adenine dinucleotide (NAD+) is an important co-factor for enzymatic reactions, including ADP-ribosylation. Although mitochondria harbor the most intra-cellular NAD+, mitochondrial ADP-ribosylation remains poorly understood. Here we provide evidence for mitochondrial ADP-ribosylation, which was identified using various methodologies including immunofluorescence, western blot, and mass spectrometry. We show that mitochondrial ADP-ribosylation reversibly increases in response to respiratory chain inhibition. Conversely, H2O2-induced oxidative stress reciprocally induces nuclear and reduces mitochondrial ADP-ribosylation. Elevated mitochondrial ADP-ribosylation, in turn, dampens H2O2-triggered nuclear ADP-ribosylation and increases MMS-induced ARTD1 chromatin retention. Interestingly, co-treatment of cells with the mitochondrial uncoupler FCCP decreases PARP inhibitor efficacy. Together, our results suggest that mitochondrial ADP-ribosylation is a dynamic cellular process that impacts nuclear ADP-ribosylation and provide evidence for a NAD+-mediated mitochondrial-nuclear crosstalk.Entities:
Keywords: ADP-ribosylation; ARTD1; DNA damage; NAD; PARP inhibitors; PARP-inhibitor; PARP1; mito-nuclear crosstalk; mitochondria; mitochondrial ADP-ribosylation
Mesh:
Substances:
Year: 2021 PMID: 33450210 PMCID: PMC7837215 DOI: 10.1016/j.molcel.2020.12.034
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970